April 29th 2025
Advanced imaging techniques enhance deep brain stimulation for depression, ensuring precise target engagement for effective treatment.
April 29th 2025
Emergency psychiatry gains recognition with a new focused practice designation, enhancing collaboration between emergency medicine and psychiatry for better patient care.
Expert Perspectives in the Recognition and Management of Postpartum Depression
View More
Southern California Psychiatry Conference
July 11-12, 2025
Register Now!
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists
View More
BURST CME™ Part I: Understanding the Impact of Huntington’s Disease
View More
Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease
View More
Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea
View More
Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment
View More
Resilience and Renewal: Enhancing Positivity and Functional Recovery After Traumatic Brain Injury
April 25th 2025Resilience is dynamic and modifiable and is associated with positive rehabilitation outcomes following brain injury. Engaging patients in interventions to develop and strengthen resilience may improve rehabilitation outcomes by promoting psychosocial adjustment, mitigating emotional distress, and enhancing community participation.
Cobenfy as Add-On Treatment for Schizophrenia Fails to Meet Primary Endpoint in Phase 3 ARISE Trial
Cobenfy as an adjunctive treatment to atypical antipsychotics did not reach the primary endpoint of the phase 3 ARISE trial, or a statistically significant difference compared with placebo with an atypical antipsychotic.